UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Powell Industries
POWL
$6.99B
| $23.4M | ﹤0.01% |
81,723
+7,257
| +10% | +$1.97M |
2023 Q4
10 quarters
|
|
852
Huntington Ingalls Industries
HII
$10.4B
| $23.3M | ﹤0.01% |
83,280
-1,848
| -2% | -$618K |
2013 Q2
52 quarters
|
|
853
Unity
U
$20.6B
| $23.3M | ﹤0.01% |
814,076
-43,141
| -5% | -$1.15M |
2020 Q4
22 quarters
|
|
854
Cytokinetics
CYTK
$8.75B
| $23.3M | ﹤0.01% |
273,031
+32,399
| +13% | +$2.33M |
2018 Q2
32 quarters
|
|
|
FPS
855
Forgent Power Solutions
FPS
$11B
| $23.1M | ﹤0.01% |
+413,941
| New | +$18.9M |
2026 Q2
0 quarters
|
|
856
Teradata
TDC
$2.84B
| $23M | ﹤0.01% |
663,517
-66,958
| -9% | -$2.04M |
2013 Q2
52 quarters
|
|
857
Wayfair
W
$14.5B
| $23M | ﹤0.01% |
248,494
+695
| +0.3% | +$51.2K |
2018 Q3
31 quarters
|
|
858
Darling Ingredients
DAR
$9.51B
| $22.9M | ﹤0.01% |
419,696
+4,820
| +1% | +$288K |
2014 Q2
48 quarters
|
|
859
Hanover Insurance
THG
$7.64B
| $22.9M | ﹤0.01% |
107,049
-1,922
| -2% | -$364K |
2013 Q2
52 quarters
|
|
860
Conagra Brands
CAG
$6.44B
| $22.9M | ﹤0.01% |
1,698,945
+22,708
| +1% | +$317K |
2013 Q2
52 quarters
|
|
861
Hancock Whitney
HWC
$5.81B
| $22.8M | ﹤0.01% |
305,420
+108,723
| +55% | +$7.43M |
2013 Q2
52 quarters
|
|
862
Lithia Motors
LAD
$6.38B
| $22.7M | ﹤0.01% |
78,309
-2,346
| -3% | -$667K |
2013 Q2
52 quarters
|
|
863
Xenon Pharmaceuticals
XENE
$3.53B
| $22.6M | ﹤0.01% |
374,748
-418
| -0.1% | -$23.2K |
2025 Q4
2 quarters
|
|
864
Moog Inc Class A
MOG.A
$11.5B
| $22.6M | ﹤0.01% |
53,229
-1,892
| -3% | -$646K |
2013 Q2
52 quarters
|
|
865
Allegro MicroSystems
ALGM
$6.63B
| $22.5M | ﹤0.01% |
323,297
-21,760
| -6% | -$1.02M |
2021 Q1
21 quarters
|
|
866
iShares Short-Term National Muni Bond ETF
SUB
$12B
| $22.5M | ﹤0.01% |
211,051
-161,757
| -43% | -$17.2M |
2025 Q4
2 quarters
|
|
867
Oshkosh
OSK
$7.73B
| $22.4M | ﹤0.01% |
146,232
-20,734
| -12% | -$2.92M |
2013 Q2
52 quarters
|
|
868
Vanguard Morningstar Value ETF
VTV
$189B
| $22.4M | ﹤0.01% |
102,593
-87,785
| -46% | -$18.3M |
2025 Q4
2 quarters
|
|
869
AptarGroup
ATR
$7.65B
| $22.3M | ﹤0.01% |
178,428
-12,101
| -6% | -$1.47M |
2023 Q1
13 quarters
|
|
870
Enpro
NPO
$6.59B
| $22.2M | ﹤0.01% |
58,901
-1,910
| -3% | -$593K |
2013 Q2
52 quarters
|
|
871
OneMain Financial
OMF
$6.45B
| $22.1M | ﹤0.01% |
363,239
-997
| -0.3% | -$56.2K |
2014 Q3
47 quarters
|
|
|
RAL
872
Ralliant Corp
RAL
$8.1B
| $22.1M | ﹤0.01% |
299,980
-192,964
| -39% | -$10.8M |
2025 Q2
4 quarters
|
|
873
Repligen
RGEN
$11B
| $22.1M | ﹤0.01% |
161,713
-2,035
| -1% | -$250K |
2014 Q3
47 quarters
|
|
|
QRVO
874
DELISTED
Qorvo
QRVO
| $21.9M | ﹤0.01% |
235,295
+18,652
| +9% | +$1.72M |
2015 Q1
45 quarters
|
|
875
Pool Corp
POOL
$5.8B
| $21.9M | ﹤0.01% |
102,046
-10,153
| -9% | -$2.03M |
2013 Q2
52 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.